Elang Mahkota Teknologi Tbk. vs Merck Tbk. — how do they compare? Elang Mahkota Teknologi Tbk. trades at Rp520 (market cap 31.63T, 17.01M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 27.4K 24h volume). The key difference: Elang Mahkota Teknologi Tbk. is far larger — about 18.6× Merck Tbk.'s market cap, and Elang Mahkota Teknologi Tbk. is more actively traded (17.01M versus 27.4K). Which is the better fit depends on your goals.
| EMTK | MERK | |
|---|---|---|
Market Cap | 31.63T | 1.7T |
Volume | 17.01M | 27.4K |
Lot | 170.14K | 274 |
Turnover | 8.87B | 105.16M |
Average Price | 521.42 | 3,837.88 |
Value | 8.87B | 105.16M |
Indicative Equilibrium Price | 515 | 3,850 |
Indicative Equilibrium Volume | 189.8K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.
Read more on EMTK →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →